Today, at the Advances in Genome Biology and Technology (AGBT) 2021 General Meeting held virtually, BioSkryb, Inc., a developer of genomic amplification technologies, announced the winners of a research grant program sponsored by the company. The grant program was created to accelerate innovation of single-cell genomic studies using the primary template-directed amplification (PTA) technology developed by BioSkryb and now commercially available as ResolveDNA™.
The recipients of the BioSkryb research grants are:
- Dr. Joseph Gleeson, Rady Professor, UCSD Department of Neurosciences, University of California, San Diego and Rady Children’s Institute for Genomic Medicine
- Dr. Shao-bin Wang, Assistant Professor of Ophthalmology, University of Virginia School of Medicine and UVA’s Center for Advanced Vision Science
These winners were chosen for effectively demonstrating the significance of their research, the hypothesis being addressed, and the human condition benefitting from the studies. Each recipient will receive up to $20,000 worth of materials required to perform a whole genome sequencing workflow. This includes a ResolveDNA™ Complete Starter Pack, sequencing of up to eight human cells, access to BaseJumper (BioSkryb’s cloud-based bioinformatics platform), and dedicated technical support.